CLNN Clene Inc.

NAS · US · Consumer Defensive · Packaged Foods · clene.com

3.920USD+1.29%Mkt Cap: 55.72M $P/E: —1d ago

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, w…

Industry Peers

Packaged Foods

The Kraft Heinz Company

$28.90BUSD

KHC

The Kraft Heinz Company

Associated British Foods plc

$13.87BUSDP/E 13.7

MKC-V

McCormick & Company, Incorporated

$13.58BUSDP/E 8.4

SJM

The J. M. Smucker Company

$12.38BUSDP/E 54.2

MKC

McCormick & Company, Incorporated

Hormel Foods Corporation

The Magnum Ice Cream Company N.V.

$9.98BUSDP/E 36.2

MICC

The Magnum Ice Cream Company N.V.

$10.24BUSDP/E 34.6

DAR

Darling Ingredients Inc.

Smithfield Foods, Inc.

$7.28BUSDP/E 6.9

PPC

Pilgrim's Pride Corporation

$6.70BUSDP/E 12.3

Key Statistics

Company

Market Cap55.72M USD

Enterprise Value62.40M USD

Revenue (TTM)197.00K USD

Gross Profit157.00K USD

Net Income (TTM)-26.17M USD

Revenue/Share0.02 USD

Last Price3.920 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees76

CountryUS

SectorConsumer Defensive

IndustryPackaged Foods

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.59

PEG—

EV/EBITDA-3.26

EV/Revenue316.73

P/S279.23

P/B-2.00

EPS (TTM)-3.52

EPS (Forward)-2.44

52W Range

3.2606% of range13.50

52W High13.50 USD

52W Low3.260 USD

Profitability

Gross Margin78.50%

Oper. Margin-5941.11%

EBITDA Margin0.00%

Profit Margin-13086.50%

ROE148.78%

ROA-144.35%

Growth

Revenue Growth233.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.55M USD

CapEx (TTM)39.00K USD

FCF Margin-5012.18%

FCF Yield-17.72%

Net Debt12.67M USD

Net Debt/EBITDA-0.66

Balance Sheet

Debt/Equity-1.23

Current Ratio3.07

Quick Ratio2.24

Book Value/Sh-1.94 USD

Cash/Share0.75 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJul 11, 2024

Analyst Consensus

Rating—

Target (Mean)32.20 USD

Upside (mean)+721.4%

Target Range20.00 USD – 50.00 USD

20.00+721.4% to mean50.00

# Analysts5

Ownership

Shares Out.14.21M

Float9.70M

Insiders16.54%

Institutions25.41%

Short Interest

Short Ratio8.0d

Short % Float9.37%

Short % Out.7.05%

Shares Short915.63K

Short (prev mo.)1.01M

Technical

SMA 504.352 (-9.9%)

SMA 2005.401 (-27.4%)

Beta0.92

S&P 52W Chg16.45%

Avg Vol (30d)109.05K

Avg Vol (10d)104.87K

Technical Indicators

RSI (14)43.1

MACD-0.1290

MACD Signal-0.1435

MACD Hist.+0.0145

BB Upper4.628 USD

BB Middle3.998 USD

BB Lower3.369 USD

BB Width31.50%

ATR (14)0.3289 USD

Vol Ratio (20d)0.32x